Skip to main content

Impact of the Sequester on NIH Funding

This post was written as an article for the Postdoc Informer, the UT Southwestern postdoctoral community's bimonthly newsletter. It is featured as the June-July 2013 issue's lead article.  -IH

In light of the Budget Control Act of 2011, a.k.a. "the sequester," the NIH is operating this year at a program level of $29.15 billion, a decrease of $1.71 billion (approximately 5.5%) from 2012. First, the good news. Because of uncertainty surrounding the effects of the sequester in the beginning of the year, non-competing continuation awards made in the early months of 2013 were generally funded at a 10% reduction from the originally committed amount. With the uncertainty now gone, these reductions will be partially restored to more closely reflect the 5.5% reduction of the total NIH budget (e.g., 2013 noncompeting grants at NIGMS will be reduced by 3.5%, and NCI will trim ongoing grants by ~6%). The bad news? While the NIH intends to keep the average size of competing awards constant at 2012 levels, it expects to fund 703 fewer competing research grants this year, a 7.8% drop (8283 in 2013, compared to 8986 in 2012). As a result, lower success rates for grant applications will be expected in most institutes this year. A full breakdown of changes in the number of competing research grants (and their dollar amounts) for each institute within the NIH is shown in the table below. The differences between 2012 and 2013 reflect a combination of the effects of sequestration, shifting budgeting priorities within the NIH, and differing budgeting strategies utilized by each institute. 


President Barack Obama's proposed Fiscal Year (FY) 2014 R&D budget, unveiled on April 10, should ease much of the pain caused by the sequester. It proposes to increase non-defense R&D support by 9.2 percent for a total of $69.6 billion. The allocation for NIH is set at $31.3 billion, an increase of $471 million (approx. 1.5%) compared with 2012. In addition, the proposed NIH budget would raise the entry-level stipend for the National Research Service Awards (NRSA) to $42,000, representing a 7% increase over the current entry-level stipend of $39,364. The budget proposes a 4% increase for subsequent levels of experience as well. As NRSA stipend levels are used as the benchmark for postdoctoral salaries at academic institutions nationwide, this clause will have a direct positive impact on the salaries of UT Southwestern postdocs. 

Obama's proposed budget it is likely to undergo significant changes once submitted to congress. In light of this, the UT Southwestern Postdoctoral Association encourages postdocs to write to members of the Senate and the House of Representatives to express support for President Obama's budget for non-defense research and development. Detailed information on contacting representatives and composing letters of support can be found on the National Postdoctoral Association's website at:  

Comments

Post a Comment

Popular posts from this blog

Developing Software: What Should Academic Researchers Keep in Mind? (Part 2)

In Part 1   of this essay, I discussed three learning points I'd gained from my encounters with faculty-developed software in my work as a technology transfer officer at an academic medical research institution. Those points were as follows:  Patents aren't a necessary prerequisite for commercializing software Be deliberate in your use of third-party code If you are going to release your source code publicly, consider doing it under a restrictive open source license When I finished writing it, I knew I had more to say on the topic. You can read Part 1 here . Below is my continuation. 4 - Figuring out the ‘thing’ that’s going to be licensed An important part of handing off a software-based technology from university to private industry is to first figure out exactly what is being handed off. This can be tricky! I’ve discovered that software, as a commercial asset, can take many forms. The licensing professional can bring a lot of clarity to the negotiations by making sure both ...
1 comment
Read more

Medical Device Companies in Texas - Breakdown by City

In a previous post  I described  the geographic distribution of pharmaceutical companies within Texas. I went back to the same   directory of Texas-based pharmaceutical and medical device companies  [see disclaimer below, *] and,  this time,  took a  look at the geographic distribution of companies working in medical devices. The list [see technical note below, **] contains a total of 171 medical device companies - almost twice the number of pharmaceutical companies listed. Here is how they are geographically distributed:  The number in each wedge = the number of medical device companies in that city. "Other" consists of  Bryan/College Station (4 companies),  Athens (3),  Corpus Christi (2),  El Paso (2),  Amarillo (1),  Beaumont/Port Arthur (1),  Longview  (1),  Lubbock  (1),  Midland (1),  Mineral Wells  (1), and  Waco  (1). As with pharmaceutical companies...
4 comments
Read more

Finding the Innovators: Recipients of Healthcare-Related SBIR Awards

The SBIR (Small Business Innovation Research) program is a federal initiative that provides funding for small businesses to engage in research and development.  Tracking SBIR awardees, I believe, should be a great method for identifying entrepreneurial, innovation-oriented players within the Texas economy.  I decided to identify which Texas-based companies in the healthcare/biomedical industry have received SBIR awards in the recent past, and how much funding they have obtained. The SBIR website contains a well-curated database of all current and past awardees (for visualizing national trends, be sure to check out their amazing "Graphical Tools" page). I pulled up a list of all SBIR awards given to Texas-based companies between 2008 and 2012 that were sponsored by the Department of Health and Human Services – thus limiting the search results to grants awarded to companies in the healthcare/biomedical industry. The list consisted of 186 grants awarded to 85 different co...
6 comments
Read more